HB 800 updates Maryland’s education law to explicitly include "student well-being and human flourishing" alongside behavioral health services. It amends sections of the education code (including 5-212, 6-122, and 7-447) to define student well-being as progress across eight dimensions: social, environmental, physical, emotional, spiritual, occupational, intellectual, and financial well-being. The bill requires school staff training to recognize issues affecting these areas and directs the Maryland Consortium on Coordinated Community Supports to advance student well-being initiatives. It directly affects Maryland public schools, staff, and students by integrating holistic well-being into existing education funding, training, and support systems.
SB 773 allows pharmacists in Maryland to order certain vaccinations (like flu, COVID-19, or emergency vaccines) for patients aged 3 and older without needing to administer the vaccine themselves. To qualify, pharmacists must complete 20 hours of approved training, hold current CPR certification, and complete 2 hours of continuing education on immunizations. The bill requires pharmacists to follow written vaccine-specific protocols, report all vaccinations to Maryland’s ImmuNet registry, and refer pediatric patients to primary care providers when appropriate. This policy directly affects pharmacists, patients seeking these vaccines, and healthcare coordination for immunizations. The changes take effect October 1, 2026.
HB 1367 establishes a Commission on Re-Imagining Health Care in Maryland to study and recommend changes for a new statewide healthcare system. The commission, composed of 20 appointed members including state officials, healthcare providers, insurers, county representatives, and community members, will examine how healthcare is delivered in other regions and address issues like provider shortages, cost balancing, and system integration. It will specifically study how to create a patient-centered system covering all health needs, eliminate access barriers, and ensure financial sustainability for all Maryland residents. The commission’s final recommendations, due by 2028, would guide potential future policy changes but do not enact any immediate healthcare reforms.
SB 891 requires health insurance companies in Maryland to provide pregnant individuals and those up to one year postpartum with a standing referral to a mental health provider without needing a new authorization each time. It also mandates coverage for perinatal mental health screenings during pregnancy and postpartum, and directs the Maryland Department of Health to create a screening program. Additionally, the bill requires health professionals renewing licenses to complete continuing education on perinatal mental health conditions. These provisions directly affect insurers, pregnant/postpartum individuals, mental health providers, and health license holders.
HB 1420 requires criminal history background checks for applicants and renewing licensees in specific healthcare professions, including nursing, dentistry, pharmacy, and others listed in the bill. Starting July 1, 2027, new applicants must submit fingerprints and pay fees to the state’s Central Repository for a criminal records check under new Section 1A-302.1. Existing licensees renewing after January 1, 2028, must also provide proof of a criminal check. The bill establishes standardized procedures for conducting these checks while ensuring confidentiality and allowing applicants to contest results.
HB 1087 requires Maryland health care facilities performing surgeries that generate surgical smoke (like hospitals, ambulatory surgical centers, and freestanding medical facilities) to adopt policies mandating the use of smoke evacuation systems by January 1, 2028. These systems must capture and filter harmful surgical smoke particles at the source before they reach medical staff or patients. The bill defines "surgical smoke" as the gaseous byproducts from energy-generating surgical tools, including bio-aerosols and lung-damaging particles. This policy change aims to protect health care workers and patients from exposure to potentially hazardous smoke during procedures.
HB 1055 requires Maryland’s Department of Health to add Gaucher disease to the state’s mandatory newborn screening program, effective October 1, 2026. This bill directly affects all newborns in Maryland by expanding the list of conditions screened during routine newborn testing, unless parents or guardians object. The key mechanism is amending Maryland’s Health Code (Section 13-111) to explicitly mandate screening for Gaucher disease, which is currently not included in the standard panel. The bill does not alter existing screening protocols or costs but ensures Gaucher disease is screened for alongside other core conditions listed in federal recommendations.
HB 1051 creates Maryland’s "Meds-to-Beds Program," requiring all state hospitals to partner with licensed pharmacists who deliver discharge medications to patients *before* they leave the hospital, aiming to reduce readmissions. It also expands insurance coverage for telehealth to include automated drug dispensing systems and remote dispensing systems, allowing pharmacies to outsource prescription processing under specific conditions. The bill directly affects hospitals (mandated to participate), pharmacists (who deliver medications), and patients (who receive timely discharge drugs). Key changes include updating telehealth definitions in insurance law and establishing new regulations for medication access systems.
SB 796 establishes new consumer protections for health care financing in Maryland by restricting how health care providers handle third-party financing (like credit cards or loans for treatment costs). It prohibits providers from applying for financing on a patient’s behalf, promoting financing to patients under anesthesia or during active treatment, or billing financiers more than 30 days before a procedure. Providers must give patients a written treatment plan and specific disclosures before discussing financing, and must issue full refunds within 15 days if treatment isn’t provided. The law applies to licensed health care providers (excluding hospitals) and aims to prevent deceptive practices while allowing financing for insurance copays or deductibles.
SB 774, the "TRUTH in Mental Health Coverage Act," requires Maryland health insurance carriers to annually report detailed claims data on mental health and substance use coverage starting in 2028. This affects all insurers offering health benefit plans in Maryland, mandating they submit standardized data on access, network availability, and coverage for services like outpatient care, telehealth, and youth/adult services. The report must include breakdowns by facility type, provider specialty, service format, and geographic area. The Maryland Insurance Commissioner will make this data publicly available through a website and interactive dashboards to improve transparency for consumers.
